3.5 TFA activation of the Notch3/Hes5 signaling pathway reverses the cardiopulmonary functional improvements in enzalutamide-treated rats and AR−/− mice with PAH. This evidence concerns the gene NOTCH3 and pulmonary arterial hypertension.